Analysis of tumoral, stromal and glycolitic markers in the response basal cell carcinoma and Bowen disease to photodynamic therapy in real life
This study emphasizes the importance of personalized approaches in the use of MAL-PDT, tailoring treatment according to tumor-specific characteristics. Biomarkers such as p53, β-catenin, and GLUT1 can serve as predictive tools for PDT response, helping clinicians identify patients who may benefit from alternative or combined treatments to enhance therapeutic efficacy.
Authors
- Ángeles Juarranz (ORCID: https://orcid.org/0000-0002-6574-2887)
- María Gallego-Rentero (ORCID: https://orcid.org/0000-0001-5767-4258)
- Yolanda Gilaberte (ORCID: https://orcid.org/0000-0001-8034-3617)
- Laura Nájera (ORCID: https://orcid.org/0000-0002-0641-0081)
- Mariana Claudia Matei (ORCID: https://orcid.org/0000-0002-7130-1113)
- Laura Bernal-Masferrer
- Tamara Gracia‐Cazaña (ORCID: https://orcid.org/0000-0002-0523-2076)
- Salvador González (ORCID: https://orcid.org/0000-0001-9282-4784)
- P Cerro
- M. Carmen Gómez-Mateo (ORCID: https://orcid.org/0000-0002-0990-7480)
Institutions
- Instituto Cajal (ES)
- Universidad de Zaragoza (ES)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Hospital Universitario Miguel Servet (ES)
- Instituto Ramón y Cajal de Investigación Sanitaria (ES)
- Instituto de Investigación Sanitaria Aragón (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Photodiagnosis and Photodynamic Therapy
- Published
- 2024-12-10
- DOI
- https://doi.org/10.1016/j.pdpdt.2024.104442
- Citations
- 3
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Ministerio de Economía y Competitividad
- Instituto de Salud Carlos III
- Direction Générale de l’Armement
- Departamento de Educación, Cultura y Deporte, Gobierno de Aragón